NEW YORK (GenomeWeb News) – Rubicon Genomics will integrate its ThruPlex technology into Diagenode's epigenetics platforms under a partnership announced today.

The deal is expected to result in improved efficiency and quality of DNA sample preparation for chromatin immunoprecipitation applications, Rubicon said.

Under the terms of the deal, Diagenode will incorporate the ThruPlex-FD technology into its MicroPlex Library Preparation Kit for ChIP-seq studies that require small sample amounts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.